Why physicians join our hematology community
Sermo’s hematology physician network provides practicing hematologists with a secure, peer-driven platform to discuss the latest in targeted therapies, clotting disorders, bone marrow transplants, and malignant hematology. Whether you’re a clinical researcher, a pediatric hematologist, or managing a broad range of blood disorders, Sermo connects you to peers facing similar challenges—from navigating access to novel gene therapies to managing complex transfusion cases and rapidly shifting treatment paradigms.
Connect with global hematology specialists
Tap into one of the largest online communities of practicing hematologists across benign and malignant hematology, oncology, pathology, and more.
Access real-time clinical discussions
Engage in peer-driven conversations on complex patient cases, diagnostic mysteries, and evolving treatment innovations.
Guide long-term care strategies
Join discussions on managing chronic hematologic conditions, coordinating with multidisciplinary teams, and guiding patients through difficult treatment journeys.
Stay ahead in emerging hematology research
Discover the latest conversations and breakthroughs in CAR-T therapy, bispecific antibodies, and novel anticoagulants—keeping you at the forefront of your field.
Make evidence-based treatment decisions
Access peer-reviewed drug ratings to support informed treatment decisions, grounded in real-world physician experience.
Collaborate on patient care solutions
Exchange frontline experiences, treatment protocols, and clinical insights with peers in a secure, physician-only community.
Earn money sharing your hematology expertise
Learn why surveys are worth it for hematologists and tackle topics such as:
- Surveys on the adoption of new anticoagulant agents
- Opinion polls on sequencing therapies in multiple myeloma
- Research studies around quality of life for sickle cell disease patients
Access hematology drug insights from peers
Get practical, peer-reviewed information on hematologic treatments:
- Detailed safety profiles of immunotherapies and targeted agents
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new therapies and practical use cases
Learn from hematology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Discussing treatment goals and side effects of chemotherapy
- Showing empathy when delivering a leukemia diagnosis
- Barriers to access for gene therapies
- Emerging treatments for rare anemias
Hear from fellow physician peers
I like the general awareness of issues and ability to think critically about different medical cases
Going onto Sermo is one of the “highlights” of the day for me.
Sermo is a very informative, useful and interesting resource. I really like the clinical cases published on the site. Nice bonus – earnings on surveys!
Frequently asked questions
Sermo’s hematology community regularly shares updates and discussions around FDA/EMA approvals, trial outcomes, and real-world experiences with new targeted therapies, immunotherapies, and anticoagulants.
Yes. Our drug ratings feature allows hematologists to review and compare medications across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for conditions like lymphoma and multiple myeloma, as well as patient recruitment challenges.
Yes. Whether you are in academic research, a large cancer center, or community practice, Sermo provides a space to share your expertise and learn from others.
You’ll find case studies ranging from perplexing bleeding disorders to managing CAR-T cell therapy complications and interpreting complex flow cytometry results.
Yes. Many discussions on Sermo focus on prior authorizations for high-cost drugs, reimbursement issues, and the operational side of running a hematology practice.
Sermo enables real-time collaboration. Post a case or a diagnostic question anonymously and receive input within hours—helping you make confident decisions when time and clarity matter most.
Sermo complements these societies with real-time peer discussion, drug insight directories, trending community polls, and paid survey opportunities.
Start your hematology journey on Sermo
Become part of a dynamic hematology physician network of over 12,000 members dedicated to improving patient outcomes and advancing care through peer collaboration and expert insights.
